Dietary Selenium, Selenoenzyme Genes and Adult Glioma
膳食硒、硒酶基因和成人神经胶质瘤
基本信息
- 批准号:8509399
- 负责人:
- 金额:$ 8.43万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-04-01 至 2015-03-31
- 项目状态:已结题
- 来源:
- 关键词:AdultAdult GliomaAnabolismAntioxidantsAreaBiological AvailabilityBloodCardiovascular DiseasesCase-Control StudiesCell physiologyCentral Nervous System NeoplasmsChemopreventive AgentClipCommunitiesDNADevelopmentDietDietary SeleniumEnvironmental Risk FactorEnzymesEtiologyEvaluationExcess MortalityFundingGCLM geneGenesGenetic Predisposition to DiseaseGenetic RiskGenetic VariationGenotypeGlioblastomaGliomaGlutathioneGrantHumanImmunityIntakeInvestigationLinkMalignant NeoplasmsMeasuresMediatingMedical centerNail plateOutcomeOxidation-ReductionParticipantPatientsPopulation StudyPrevention ResearchResearchResourcesRiskRisk FactorsRoleSeleniumSingle Nucleotide PolymorphismStructure of nail of toeTrace Elementsbasecancer preventioncost effectivegene functionmortalityprogramspublic health relevanceresponseselenoenzymeselenoproteintumor
项目摘要
DESCRIPTION (provided by applicant): The proposal is submitted in response to PAR-11-079 (Cancer Prevention Research Small Grant Program). Glioma is a lethal human malignancy of unknown etiology. The aims of this project are to conduct an exploratory investigation on the relationships of selenium (Se), an essential trace mineral linked to cancer and cardiovascular disease, and genetic variation in selenoproteins which mediate the major cellular functions of Se, with risk and survival in glioma. Increased intake of Se has been suggested to have anticarcinogenic effects through cellular protective and redox antioxidant functions, though no population study has yet examined the role of Se in glioma. The project will be based on a multicenter NCI-funded (R01 CA116174) case-control study exploring genetic and environmental risk factors for adult glioma underway at medical centers in the Southeastern US. Nail clippings for assessment of trace elements and DNA for study of genetic susceptibility are available for all study participants. Specific aims of this project are to: 1) Measure toenail Se i 250 incident glioma cases and 250 matched community controls; 2) Genotype functional or tagging single nucleotide polymorphisms (SNPs) in the selenoenzymes in approximately1200 cases and 1200 controls; and 3) Evaluate associations of dietary Se and selenoenzyme genotypes for relationships with glioma risk and patient outcome. To our knowledge, this will be the first study to investigate dietary Se as a glioma risk factor. The project will also provide th first comprehensive evaluation of genetic variation in selenoenzymes in glioma. Based on a large, completed case-control study, the project offers cost-effective and timely new information on a potential dietary risk factor, mechanisms for tumor development, and promising new areas for research.
描述(由申请人提供):该提案是针对Par-11-079(预防癌症研究小补助计划)提交的。神经胶质瘤是未知病因的致命人类恶性肿瘤。该项目的目的是对硒(SE)的关系进行探索性研究,硒(SE),与癌症和心血管疾病相关的必不可少的痕量矿物质,以及硒蛋白的遗传变异,介导SE的主要细胞功能,在SE的主要细胞功能,具有风险和存活率神经胶质瘤。尽管尚无人群研究尚未检查SE在神经胶质瘤中的作用,但已建议通过细胞保护性和氧化还原抗氧化功能的摄入量增加来具有抗癌作用。该项目将基于由NCI资助的(R01 CA116174)的病例对照研究,探讨美国东南部医疗中心成人神经胶质瘤的遗传和环境危险因素。用于评估痕量元素和DNA的指甲剪辑可用于所有研究参与者。该项目的具体目的是:1)测量Toenail SE I 250事件胶质瘤病例和250个匹配的社区控制; 2)在大约1200例和1200个对照中,基因型功能或标记单核苷酸多态性(SNP); 3)评估饮食中的SE和硒酶基因型与神经胶质瘤风险和患者结局的关系。据我们所知,这将是首次研究作为神经胶质瘤危险因素的饮食中SE的研究。该项目还将对神经胶质瘤中硒酶的遗传变异进行首次全面评估。基于一项大型,完整的病例对照研究,该项目提供了有关潜在的饮食危险因素,肿瘤发育机制以及有希望的新研究领域的成本效益和及时的新信息。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kathleen M. Egan其他文献
Relative survival rates after alternative therapies for uveal melanoma.
葡萄膜黑色素瘤替代疗法后的相对存活率。
- DOI:
10.1016/s0161-6420(90)32512-5 - 发表时间:
1990 - 期刊:
- 影响因子:13.7
- 作者:
J. Seddon;E. Gragoudas;Kathleen M. Egan;Robert J. Glynn;Suzanne Howard;Robert G. Fante;Daniel M. Albert - 通讯作者:
Daniel M. Albert
Long-term results of proton beam irradiated uveal melanomas.
质子束照射葡萄膜黑色素瘤的长期结果。
- DOI:
10.1016/s0161-6420(87)33456-6 - 发表时间:
1987 - 期刊:
- 影响因子:13.7
- 作者:
E. Gragoudas;J. Seddon;Kathleen M. Egan;Robert J. Glynn;J. Munzenrider;Mary Austin;M. Goitein;Lynn Verhey;Marsha Urie;Andreas Koehler - 通讯作者:
Andreas Koehler
Lens changes after proton beam irradiation for uveal melanoma.
质子束照射葡萄膜黑色素瘤后晶状体发生变化。
- DOI:
10.1016/s0002-9394(14)73868-1 - 发表时间:
1995 - 期刊:
- 影响因子:4.2
- 作者:
Kathleen M. Egan;E. Gragoudas;S. M. Walsh;S. Regan;J. Munzenrider;Victor Taratuta - 通讯作者:
Victor Taratuta
Microbiology of contact lens-related keratitis.
隐形眼镜相关角膜炎的微生物学。
- DOI:
10.1097/00003226-198912000-00011 - 发表时间:
1989 - 期刊:
- 影响因子:2.8
- 作者:
Oliver D. Schein;L. David Ormerod;Elena Barraquer;Eduardo Alfonso;Kathleen M. Egan;Barbara G. Paton;Kenneth R. Kenyon - 通讯作者:
Kenneth R. Kenyon
Visual outcome after proton beam irradiation of uveal melanoma.
质子束照射葡萄膜黑色素瘤后的视觉结果。
- DOI:
10.1016/s0161-6420(86)33700-x - 发表时间:
1986 - 期刊:
- 影响因子:13.7
- 作者:
Johanna M. Seddon;E. Gragoudas;L. Polivogianis;Chung;Kathleen M. Egan;M. Goitein;Lynn Verhey;J. Munzenrider;Mary Austin;M. Urie;Andreas Koehler - 通讯作者:
Andreas Koehler
Kathleen M. Egan的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kathleen M. Egan', 18)}}的其他基金
Transplanting Unique Human Microbiomes to Improve Immunotherapy in Glioblastoma
移植独特的人类微生物组以改善胶质母细胞瘤的免疫治疗
- 批准号:
10216471 - 财政年份:2021
- 资助金额:
$ 8.43万 - 项目类别:
Sequence variation in mtDNA and extreme survival in glioblastoma
mtDNA 的序列变异与胶质母细胞瘤的极端生存
- 批准号:
9307011 - 财政年份:2017
- 资助金额:
$ 8.43万 - 项目类别:
Dietary Selenium, Selenoenzyme Genes and Adult Glioma
膳食硒、硒酶基因和成人神经胶质瘤
- 批准号:
8627152 - 财政年份:2013
- 资助金额:
$ 8.43万 - 项目类别:
Methylmercury exposure, mercury metabolism genotypes, and risk of adult glioma
甲基汞暴露、汞代谢基因型和成人神经胶质瘤的风险
- 批准号:
8582978 - 财政年份:2013
- 资助金额:
$ 8.43万 - 项目类别:
Methylmercury exposure, mercury metabolism genotypes, and risk of adult glioma
甲基汞暴露、汞代谢基因型和成人神经胶质瘤的风险
- 批准号:
8693972 - 财政年份:2013
- 资助金额:
$ 8.43万 - 项目类别:
Moffitt Postdoctoral Training Program in Molecular & Genetic Epidemiology
莫菲特分子博士后培训计划
- 批准号:
8076216 - 财政年份:2010
- 资助金额:
$ 8.43万 - 项目类别:
Moffitt Postdoctoral Training Program in Molecular & Genetic Epidemiology
莫菲特分子博士后培训计划
- 批准号:
8490701 - 财政年份:2010
- 资助金额:
$ 8.43万 - 项目类别:
Moffitt Postdoctoral Training Program in Molecular & Genetic Epidemiology
莫菲特分子博士后培训计划
- 批准号:
8677770 - 财政年份:2010
- 资助金额:
$ 8.43万 - 项目类别:
Moffitt Postdoctoral Training Program in Molecular & Genetic Epidemiology
莫菲特分子博士后培训计划
- 批准号:
8270383 - 财政年份:2010
- 资助金额:
$ 8.43万 - 项目类别:
Moffitt Postdoctoral Training Program in Molecular & Genetic Epidemiology
莫菲特分子博士后培训计划
- 批准号:
7849273 - 财政年份:2010
- 资助金额:
$ 8.43万 - 项目类别:
相似海外基金
The hypoxic niche in glioblastoma is maintained by myeloid produced creatine
胶质母细胞瘤中的缺氧生态位由骨髓产生的肌酸维持
- 批准号:
10638880 - 财政年份:2023
- 资助金额:
$ 8.43万 - 项目类别:
Targeting metabolic vulnerabilities induced by the 1p19q codeletion in oligodendrogliomas
针对少突胶质细胞瘤中 1p19q 编码缺失引起的代谢脆弱性
- 批准号:
10722255 - 财政年份:2023
- 资助金额:
$ 8.43万 - 项目类别:
ATIC is a novel molecular target in diffuse intrinsic pontine glioma
ATIC是弥漫性内源性脑桥胶质瘤的新型分子靶点
- 批准号:
10712984 - 财政年份:2023
- 资助金额:
$ 8.43万 - 项目类别:
Harvard/Stanford GTN Program: Novel targeted therapeutics for glioblastoma
哈佛/斯坦福 GTN 项目:胶质母细胞瘤的新型靶向疗法
- 批准号:
10306226 - 财政年份:2021
- 资助金额:
$ 8.43万 - 项目类别:
Exploiting Pyrimidine Nucleotide Synthesis Dependence for IDH Mutant Glioma Therapy
利用嘧啶核苷酸合成依赖性进行 IDH 突变胶质瘤治疗
- 批准号:
10180738 - 财政年份:2021
- 资助金额:
$ 8.43万 - 项目类别: